GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getein Biotech Inc (SHSE:603387) » Definitions » Sale Of Investment

Getein Biotech (SHSE:603387) Sale Of Investment : ¥52 Mil (TTM As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Getein Biotech Sale Of Investment?

Getein Biotech's sale of investment for the three months ended in Jun. 2024 was ¥156 Mil. It means Getein Biotech gained ¥156 Mil from selling investments. Getein Biotech's sale of investment for the trailing twelve months (TTM) ended in Jun. 2024 was ¥52 Mil.

Compared with last quarter (¥81 Mil in Mar. 2024 ), Getein Biotech gained more money from selling investments in Jun. 2024 (¥156 Mil).


Getein Biotech Sale Of Investment Historical Data

The historical data trend for Getein Biotech's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getein Biotech Sale Of Investment Chart

Getein Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 462.74 45.50 56.81 478.99 322.88

Getein Biotech Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 321.53 92.33 -277.71 80.72 156.37

Getein Biotech Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Getein Biotech Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Getein Biotech's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Getein Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505
Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.
Executives
Su En Kui Director
Yan Bin Director
Kong Ting Ting Director
Xu Xing De Director
Su En Ben Director

Getein Biotech Headlines

No Headlines